Malaria poses serious problems in countries located in tropical and subtropical regions worldwide. Plasmodium falciparum is responsible for approximately 90 % of malaria-related deaths worldwide. Therefore, alternative treatments are required to effectively reduce the number of malaria cases. Therefore, the objective of this study was to explore alternative malaria treatments by identifying compounds targeting P. falciparum plasmepsin X and characterizing the interactions under various temperatures. Molecular docking was used to evaluate interactions between polyphenolic compounds from Saussurea pulchella and plasmepsin X, followed by stability analyses using molecular dynamics (MD) simulations. Selected compounds were analyzed for biological activity, reactivity, and toxicity. RMSD (root mean square deviation), RMSF (root mean square fluctuation), Rg (radius of gyration), SASA (solvent-accessible surface area), and H-bonds were evaluated. Furthermore, MM-PBSA (molecular mechanics Poisson–Boltzmann surface area), PCA (principal component analysis), and DCCM (dynamic cross-correlation matrix) were use to evaluate effects of various temperatures. Pinoresinol 4-glucoside had a binding energy of 10.006 kcal/mol and was predicted to be nontoxic. MD simulations of pinoresinol 4-glucoside were conducted at different temperatures (298 K, 300 K, 305 K, 310 K, and 320 K) over a trajectory of 150 ns, revealing a strong binding energy using the MM-PBSA method. Our findings suggest that pinoresinol 4-glucoside is an alternative treatment for malaria and should be further evaluated at the laboratory and clinical levels.
19 September 2024 in Journal of Taibah University Medical Sciences
Alzheimer's disease (AD) is posing an increasing global threat and currently lacks effective treatments. Therefore, this study was aimed at exploring phytochemicals in Scabiosa columbaria (S. columbaria) as inhibitors of acetylcholinesterase (AChE), β-site APP cleavage enzyme 1 (BACE1), and TNF-α converting enzyme (TACE) in AD. S. columbaria contains various bioactive compounds, such as chlorogenic acid, linalool, and catechins, which are known for their detoxification properties, capacity to resist and manage harmful moisture buildup, and therapeutic roles in COVID-19. Several studies have also shown that S. columbaria extract has strong antioxidant activity, and may potentially decrease neuroinflammation in AD. Therefore, this study investigated the interactions between S. columbaria phytochemicals and key enzymes associated with AD, thus providing opportunities for the development of new therapeutic candidates. A total of 27 phytochemicals were evaluated for their inhibitory activity against AChE, BACE1, and TACE with YASARA Structure. ADMET profiles and toxicity were assessed. The top candidate compounds underwent 100 ns MD simulations. All ligands met Lipinski's rule and showed low toxicity. Catechins, compared with the known drug galantamine, showed higher inhibitory activity and interacted with additional active sites on AChE, thus suggesting potentially higher efficacy. Moreover, chlorogenic acid showed stronger inhibitory activity against TACE than the control drug (aryl-sulfonamide), thereby suggesting a different mechanism of action. MD simulation revealed that the formed complexes had good stability. However, further exploration is necessary. S. columbaria derivative compounds are promising drug candidates because of their properties, including the affinity of chlorogenic acid toward TACE and hydrogen bond enhancing ligand–receptor interactions. MD simulation indicated stable ligand–protein complexes, and the radius of gyration and MM-PBSA calculations revealed favorable binding and interaction energies. Our findings demonstrate the identified compounds' potential for further drug development.
30 October 2024 in Biochemical and Biophysical Research Communications
Obesity, a prevalent metabolic disorder characterized by excessive fat accumulation, can severely affect overall health if left untreated. This study investigated the potential of a 70% ethanol extract from Piper crocatum (red betel) leaves as an in vitro inhibitor of pancreatic lipase (PL), supported by computational analyses to identify alternative compounds to orlistat. The phytochemical profile was characterized using LC-MS/MS, revealing alkaloids and terpenoids with contents of 1.1 ± 0.01 mg CE/g and 3.14 ± 0.3 mg UAE/g, respectively. The extract exhibited 49 ± 9.1% inhibition of PL activity. Molecular docking identified three promising compounds: calanolide A (10.43 kcal/mol), myricanone (10.04 kcal/mol), and (-)-8-prenylnaringenin (9.49 kcal/mol). Based on DFT studies, these compounds showed favorable ADMET and electronic properties. MD simulations demonstrated that the PL-calanolide A complex maintained high conformational stability over 100 ns with a binding energy of 150.75 kJ/mol (MM-PBSA). These findings suggest that red betel leaf extract may serve as a promising natural pancreatic lipase inhibitor, as supported by robust in vitro and computational evidence supporting its potential for future anti-obesity drug development.